- Preview Available
- Scholarly Journal
Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients
Scientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 18669.
DOI:10.1038/s41598-025-97923-2
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.